Effect of fiber supplementation on the microbiota in critically ill patients

Table 1 Demographic details of the patients studied, with outline of medications received and outcome

Patient	Diagnosis	Age (yr)	Sex	BMI (kg/m2)	Duration of fiber suppl (d)	Maximum fiber (g/d)	Medications, gastrointestinal symptoms before feeding, outcome
Group 1: bolus injections: short term
1	Trauma	59	M	34.7	3	15	Metronidazole, lanzoprazole, diarrhea, d/c to snf
2	SAP	65	M	38.0	8	29	Cefepime, lanzoprazole, diarrhea, discharge home
3	SAP	85	F	31.0	3	24	Omeprazole, diarrhea, discharge home
4	SAP	89	F	29.4	6	32	Fluconazole, lanzoprazole, transfer rehab
5	SAP	43	M	34.7	9	12	Fluconazole, vancomycin, pantoprazole, discharge home
6	SAP	34	M	44.8	3	18	Ertapenem, omeprazole, diarrhea, d/c to snf
7	SAP	81	F	35.5	3	15	Omeprazole, discharge home
8	SAP	62	M	27.0	7	22	Famotidine, metronidazolel, discharge home
9	SAP	56	M	28.7	6	24	Trimethoprim-sulfamethoxazole, voriconazole, pantoprazole, discharge home
Group 2: continuous infusions: long term
10	SAP	88	F	30.3	19	35	Metronidazole, aztreonam, famotidine, diarrhea transfer to snf
11	SAP	65	F	27.6	36	36	Piperacillin-tazobactam, doripenem, metronidazole, pantoprazole, cefuroxime, diarrhea, distension, pain. d/c to snf
12	SAP	47	F	31.0	33	18	Piperacillin-tazobactam, pantoprazole, fluconazole, metronidazole, vancomycin, diarrhea, distention, d/c to snf
13	Chronic sepsis C diff	79	F	34.9	23	24	Metronidazole, vancomycin, lanzoprazole, diarrhea, distension, pain. Clostridium difficile. d/c to snf

SAP: Severe acute pancreatitis; d/c: Discharge; snf: Skilled nursing facility; BMI: Body mass index.